Literature DB >> 16194196

Factor V Leiden and prothrombin G20210A polymorphisms as risk factors for miscarriage during a first intended pregnancy: the matched case-control 'NOHA first' study.

G Lissalde-Lavigne1, P Fabbro-Peray, E Cochery-Nouvellon, E Mercier, S Ripart-Neveu, J-P Balducchi, J-P Daurès, T Perneger, I Quéré, M Dauzat, P Marès, J-C Gris.   

Abstract

Factor V Leiden (FVL) and prothrombin G20210A (FIIG20210A) mutations are associated with a higher risk of miscarriage: we sought to understand whether this association differs by clinical time of unexplained miscarriage, and by ethnic origin, among women with no previous thrombotic episode, during the first intended pregnancy. We performed a case-control study nested in a cohort of 32 683 women. We analyzed 3496 pairs of women matched for classical confounding factors. The FVL and FIIG20210A mutations were associated with an increased risk of miscarriage in Caucasian women [odds ratio (OR) 3.19, 95% confidence interval (CI) 2.37-4.30, P < 0.001 and OR 2.36, 95% CI, 1.72-3.24, P < 0.001, respectively]. Among non-Caucasian women, the mutations were rare and the associations with risk of miscarriage less clear. FVL and FIIG20210A mutations were independent risk factors for miscarriages only for women with related clinical signs occurring from the 10th week of gestation on (OR 3.46, 95% CI 2.53-4.72, P < 0.001 and OR 2.60, 95% CI 1.86-3.64, P < 0.001, respectively). These results indicate that FVL and FIIG20210A mutations are associated with a significant risk of spontaneous abortion which clinical signs occur from the 10th week on of the first intended pregnancy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16194196     DOI: 10.1111/j.1538-7836.2005.01581.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  12 in total

Review 1.  'To test or not to test', the arguments for and against thrombophilia testing in obstetrics.

Authors:  Laura Ormesher; Louise E Simcox; Clare Tower; Ian A Greer
Journal:  Obstet Med       Date:  2017-03-08

2.  Obstetric outcomes of recurrent pregnancy loss patients diagnosed wıth inherited thrombophilia.

Authors:  C Karadağ; T Yoldemir; S D Karadağ; C İnan; Z N Dolgun; L Aslanova
Journal:  Ir J Med Sci       Date:  2017-02-07       Impact factor: 1.568

3.  A common polymorphism in NR1H2 (LXRbeta) is associated with preeclampsia.

Authors:  Kevin Mouzat; Eric Mercier; Anne Polge; Alexandre Evrard; Silvère Baron; Jean-Pierre Balducchi; Jean-Paul Brouillet; Serge Lumbroso; Jean-Christophe Gris
Journal:  BMC Med Genet       Date:  2011-10-26       Impact factor: 2.103

4.  Fetal gene defects precipitate platelet-mediated pregnancy failure in factor V Leiden mothers.

Authors:  Rashmi Sood; Mark Zogg; Randal J Westrick; Yi-He Guo; Edward J Kerschen; Guillermina Girardi; Jane E Salmon; Shaun R Coughlin; Hartmut Weiler
Journal:  J Exp Med       Date:  2007-04-16       Impact factor: 14.307

Review 5.  The role of thrombophilia in pregnancy.

Authors:  Elisabeth M Battinelli; Ariela Marshall; Jean M Connors
Journal:  Thrombosis       Date:  2013-12-18

6.  Associations of recurrent miscarriages with chromosomal abnormalities, thrombophilia allelic polymorphisms and/or consanguinity in Saudi Arabia.

Authors:  Rola F Turki; Mourad Assidi; Huda A Banni; Hanan A Zahed; Sajjad Karim; Hans-Juergen Schulten; Muhammad Abu-Elmagd; Abdulrahim A Rouzi; Osama Bajouh; Hassan S Jamal; Mohammed H Al-Qahtani; Adel M Abuzenadah
Journal:  BMC Med Genet       Date:  2016-10-10       Impact factor: 2.103

Review 7.  Recurrent pregnancy loss: current perspectives.

Authors:  Hady El Hachem; Vincent Crepaux; Pascale May-Panloup; Philippe Descamps; Guillaume Legendre; Pierre-Emmanuel Bouet
Journal:  Int J Womens Health       Date:  2017-05-17

8.  Fetoplacental discrepancy with normal karyotype in amniotic fluid and two different cell lines in placenta.

Authors:  Veronica Ortega; Christina Mendiola; Eric Williamson; Kenneth Higby; Gopalrao V N Velagaleti
Journal:  Case Rep Genet       Date:  2013-06-13

9.  The 5, 10 methylenetetrahydrofolate reductase C677T mutation and risk of fetal loss: a case series and review of the literature.

Authors:  Ivy Altomare; Alan Adler; Louis M Aledort
Journal:  Thromb J       Date:  2007-10-17

10.  THBD sequence variants potentially related to recurrent pregnancy loss.

Authors:  Paula Quintero-Ronderos; Eric Mercier; Jean-Christophe Gris; Clara Esteban-Perez; Harold Moreno-Ortiz; Dora Janeth Fonseca; Elkin Lucena; Daniel Vaiman; Paul Laissue
Journal:  Reprod Biol Endocrinol       Date:  2017-12-01       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.